Date sent: Tue, 1 Aug 2000 The Human/Animal Interaction in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: A Look at 127 Patients Journal of Chronic Fatigue Syndrome, Vol. 6 No. 2, 2000, pp. 65-72 R. Tom Glass, DDS, PhD ABSTRACT. Objective: To evaluate the interaction between Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients and domestic animals (pets). Design: Retrospective study of criteria-met ME/CFS patients using a standardized questionnaire which included patient comments. Setting: University medical center and ME/CFS support groups throughout the United States. Patients: A total of 127 patients met the surveillance criteria of the Centers for Disease Control and Prevention (CDC) for the establishment of the diagnosis of ME/CFS and were included in the study. Measurements: Information from the standardized questionnaire was compiled and appropriate statistical tests, including mean, median, Z test, multivariant analysis, and Chi-square test, were used. This information was compared to national statistical information on animal interaction compiled by the American Veterinary Medicine Association. Results: The most striking result of the study was the association between ME/CFS patients and animals (usually indoor pets) and the number of animals per ME/CFS patient. Ninety-seven percent of the ME/CFS patients had animal contact (expected national contact: 57.9%), with only 2 males and 2 females not reporting animal contact. Reported dog ownership/household for ME/CFS males was 9.5 and for ME/CFS females was 7.9 (expected national average: 1.52). Reported cat ownership/household for ME/CFS males was 6.1 and for ME/CFS females was 8.7 (expected national average: 1.95). One hundred and six of the respondents (83.5%) reported that their animals (pets) had atypical diseases with symptoms which mimicked ME/CFS in humans. Of the 106 ME/CFS patients, 100 (94.3%) either were the primary caregiver for the sick animals or had intimate contact (sleeping with, being bitten or scratched by, or kissing the animal). Conclusions: ME/CFS patients have a significant animal interaction and a large number of these animals have atypical or unusual diseases which at least mimic ME/CFS. KEYWORDS. PETS, viral disease INTRODUCTION Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease complex which was first defined in 1988, but may have been recognized under other names for a number of years (1). The disease process has multiple manifestations, however, the hallmark symptom is that of fatigue, allowing only 50% of daily activity. The fatigue must last in excess of six months. Other symptoms which are common include behavioral changes (depression and cognitive disorders being the most common), lymphadenopathy, pharyngitis, myalgia and muscle weakness, arthralgia, body temperature changes (both hypothermia and hyperthermia), and an array of immune competency changes (including none at all) (2,3). While this definition was debated in a 1992 NIH Conference, the consensus of the Workshop was to retain the 1988 definition (4). Anecdotal reports have often linked domestic animals with ME/CFS, but no formal scientific studies have been reported (5,6). Specifically, cats and dogs have been implicated by their owners. The usual association has been the presence of the animal in the household of ME/CFS patients followed by strange diseases in the animal, many of which mimic ME/CFS. The symptoms in the animals have often necessitated euthanasia. Both dogs and cats are known to be susceptible to a wide range of viruses, but with the exception of rabies, no zooriotic viral infection has been demonstrated between these typical domestic animals and humans (7). Recent observations from our animal biopsy service have demonstrated two interesting findings in animals of ME/CFS patients (unpublished data). Gingival biopsies from cats have demonstrated an unusual epithelial viral vesicle associated with an equally unusual submucosal inflammatory response. Several melanomas have been found in dogs of ME/CFS patients with the unique feature of a striking progression of the tumor in the absence of an inflammatory response. ________________________________ R.Tom Glass is Professor of Pathology and Director of the Graduate Program in Forensic Sciences, College of Osteopathic Medicine, Oklahoma State University, and Professor Emeritus of Oral and Maxillofacial Pathology, University of Oklahoma Health Sciences Center. Address correspondence to: Dr. R. Tom Glass, College of Osteopathic Medicine, Oklahoma State University, 1111 West 17th Street, Tulsa, OK 74107-1898. Research funded by: The J. Dean Robertson Society, University of Oklahoma, Grant C5185801. Journal of Chronic Fatigue Syndrome, Vol. 6(2) 2000 © 2000 by The Haworth Press, Inc. All rights reserved.